Skip to main content
. 2015 Oct 16;94(41):e1526. doi: 10.1097/MD.0000000000001526

FIGURE 3.

FIGURE 3

Five-year recurrence-free survival rate of high-risk patients according to NIH classification and TNM systems. The 5-year recurrence-free survival rates were 91.6% in stage II, 74.1% in stage IIIA, and 48.6% in stage IIIB patients.